Daclizumab (DAC) ± mycophenolate mofetil (MMF) for control of graft-versus-host disease (GVHD) in allogeneic stem cell transplant patients with cyclosporine or tacrolimus intolerance.

被引：0
|
作者：
Abhyankar, S [1 ]
Day, SD [1 ]
Barnhart, C [1 ]
Belt, RJ [1 ]
McGuirk, JP [1 ]
机构：
[1] Oncol & Hematol Associates, BMT Program, Kansas City, MO USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5181
引用
收藏
页码：353B / 353B
页数：1
相关论文
共 50 条
  • [1] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation
    Kasper, C
    Mügge, L
    Schilling, K
    Scholl, S
    Wollina, K
    Höffken, K
    Sayer, H
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S188
  • [2] Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
    Dvorak, C. C.
    Callard, E.
    Agarwal, R.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (03) : 253 - 254
  • [3] Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus
    C C Dvorak
    E Callard
    R Agarwal
    [J]. Bone Marrow Transplantation, 2006, 38 : 253 - 254
  • [4] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    [J]. TRANSPLANTATION, 1999, 67 (04) : 499 - 504
  • [5] Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): Safety analysis
    Nash, RA
    Furlong, T
    Storb, R
    Anasetti, C
    Appelbaum, FR
    Deeg, HJ
    Doney, K
    Martin, P
    Witherspoon, R
    Sullivan, KM
    [J]. BLOOD, 1997, 90 (10) : 459 - 459
  • [6] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Cheung, YK
    Van De Ven, C
    del Toro, G
    Garvin, J
    George, D
    Bradley, MB
    Wolownik, K
    Wischhover, C
    Levy, J
    Skerrett, D
    Cairo, MS
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 246 - 258
  • [7] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    Kasper, C
    Sayer, HG
    Mügge, LO
    Schilling, K
    Scholl, S
    Issa, MC
    Höffken, K
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 65 - 69
  • [8] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors
    C Kasper
    H G Sayer
    L O Mügge
    K Schilling
    S Scholl
    M C Issa
    K Höffken
    [J]. Bone Marrow Transplantation, 2004, 33 : 65 - 69
  • [9] Treatment of refractory chronic Graft-Versus-Host disease (GVHD) with Mycophenolate Mofetil (MMF).: Preliminary results
    Moscardó, F
    Sanz, G
    Jiménez, C
    Mollá, S
    Martinez, J
    Saavedra, S
    García, I
    Andreu, R
    Regadera, A
    Plumé, G
    Martin, G
    de la Rubia, J
    Cervera, J
    Jarque, I
    Sanz, M
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S190 - S190
  • [10] Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients
    Kiehl, MG
    Schäfer-Eckart, K
    Kröger, M
    Bornhäuser, M
    Basara, N
    Blau, IW
    Kienast, J
    Fauser, AA
    Ehninger, G
    Armstrong, VW
    Shipkova, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2922 - 2924
12345